Bijan Ahvazi

Array ( [id] => 5361685 [patent_doc_number] => 20090036479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'METHOD OF INHIBITING CHOROIDAL NEOVASCUARIZATION' [patent_app_type] => utility [patent_app_number] => 12/244655 [patent_app_country] => US [patent_app_date] => 2008-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6587 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20090036479.pdf [firstpage_image] =>[orig_patent_app_number] => 12244655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6644734 [patent_doc_number] => 20100227868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'TREATMENT METHODS WITH BRIMONIDINE' [patent_app_type] => utility [patent_app_number] => 12/677880 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 552 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227868.pdf [firstpage_image] =>[orig_patent_app_number] => 12677880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10851127 [patent_doc_number] => 08877809 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-04 [patent_title] => 'Compositions and methods for treating macular degeneration' [patent_app_type] => utility [patent_app_number] => 12/733631 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11778 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12733631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6645291 [patent_doc_number] => 20100227917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'EYE DROP CONTAINING DIBENZ[b,e]OXEPIN DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/676888 [patent_app_country] => US [patent_app_date] => 2008-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10105 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227917.pdf [firstpage_image] =>[orig_patent_app_number] => 12676888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324410 [patent_doc_number] => 20090062400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Method of treating glaucoma using rasagiline' [patent_app_type] => utility [patent_app_number] => 12/231601 [patent_app_country] => US [patent_app_date] => 2008-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7746 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062400.pdf [firstpage_image] =>[orig_patent_app_number] => 12231601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7772940 [patent_doc_number] => 08119112 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid' [patent_app_type] => utility [patent_app_number] => 12/203384 [patent_app_country] => US [patent_app_date] => 2008-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9650 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119112.pdf [firstpage_image] =>[orig_patent_app_number] => 12203384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5337920 [patent_doc_number] => 20090054384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'AIRWAY ALKALINIZATION AS THERAPY FOR AIRWAY DISEASES' [patent_app_type] => utility [patent_app_number] => 12/196668 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11967 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054384.pdf [firstpage_image] =>[orig_patent_app_number] => 12196668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949046 [patent_doc_number] => 20080305172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'OPHTHALMIC DEPOT FORMULATIONS FOR PERIOCULAR OR SUCONJUNCTIVAL ADMINISTRATION' [patent_app_type] => utility [patent_app_number] => 12/194617 [patent_app_country] => US [patent_app_date] => 2008-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2870 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305172.pdf [firstpage_image] =>[orig_patent_app_number] => 12194617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987430 [patent_doc_number] => 20110098359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'Compositions and Methods for Treatment of Glaucoma' [patent_app_type] => utility [patent_app_number] => 12/672475 [patent_app_country] => US [patent_app_date] => 2008-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2738 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098359.pdf [firstpage_image] =>[orig_patent_app_number] => 12672475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9582333 [patent_doc_number] => 08772337 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Preservative-free prostaglandin-based ophthalmic solution' [patent_app_type] => utility [patent_app_number] => 12/666778 [patent_app_country] => US [patent_app_date] => 2008-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4422 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12666778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6484173 [patent_doc_number] => 20100008993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'Compositions and Methods for Increasing Bioavailability of Topical Ophthalmic Drugs' [patent_app_type] => utility [patent_app_number] => 12/172325 [patent_app_country] => US [patent_app_date] => 2008-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8633 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20100008993.pdf [firstpage_image] =>[orig_patent_app_number] => 12172325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8164696 [patent_doc_number] => 08173668 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-05-08 [patent_title] => 'Use of non-peptidic bradykinin receptor agonists to treat ocular hypertension and glaucoma' [patent_app_type] => utility [patent_app_number] => 12/134002 [patent_app_country] => US [patent_app_date] => 2008-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19008 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/173/08173668.pdf [firstpage_image] =>[orig_patent_app_number] => 12134002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5295924 [patent_doc_number] => 20090010850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Formulations and methods for treating dry eye' [patent_app_type] => utility [patent_app_number] => 12/154665 [patent_app_country] => US [patent_app_date] => 2008-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 15914 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20090010850.pdf [firstpage_image] =>[orig_patent_app_number] => 12154665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8533457 [patent_doc_number] => 08309612 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-13 [patent_title] => 'Method for treating age-related macular degeneration' [patent_app_type] => utility [patent_app_number] => 12/451368 [patent_app_country] => US [patent_app_date] => 2008-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4633 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12451368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949868 [patent_doc_number] => 20080305994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Pharmaceutical Compositions and Method for Treating, Reducing, Ameliorating, Alleviating, or Preventing Dry Eye' [patent_app_type] => utility [patent_app_number] => 12/124599 [patent_app_country] => US [patent_app_date] => 2008-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12758 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305994.pdf [firstpage_image] =>[orig_patent_app_number] => 12124599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465742 [patent_doc_number] => 20120270910 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2012-10-25 [patent_title] => 'PHARMACEUTICAL CONTAINING PPAR-DELTA AGONIST' [patent_app_type] => utility [patent_app_number] => 12/451564 [patent_app_country] => US [patent_app_date] => 2008-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9460 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12451564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465742 [patent_doc_number] => 20120270910 [patent_country] => US [patent_kind] => A2 [patent_issue_date] => 2012-10-25 [patent_title] => 'PHARMACEUTICAL CONTAINING PPAR-DELTA AGONIST' [patent_app_type] => utility [patent_app_number] => 12/451564 [patent_app_country] => US [patent_app_date] => 2008-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9460 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12451564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6592503 [patent_doc_number] => 20100130569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'PROPHYLACTIC OR THERAPEUTIC AGENT FOR POSTERIOR OCULAR DISEASE COMPRISING NON-ERGOT SELECTIVE D2 RECEPTOR AGONIST AS ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 12/451282 [patent_app_country] => US [patent_app_date] => 2008-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6185 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130569.pdf [firstpage_image] =>[orig_patent_app_number] => 12451282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273612 [patent_doc_number] => 08637544 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Neurite formation promoter' [patent_app_type] => utility [patent_app_number] => 12/596581 [patent_app_country] => US [patent_app_date] => 2008-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 6721 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12596581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6427078 [patent_doc_number] => 20100168250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'USE OF CYCLOHEXANEHEXOL DERIVATIVES IN THE TREATMENT OF OCULAR DISEASE' [patent_app_type] => utility [patent_app_number] => 12/594951 [patent_app_country] => US [patent_app_date] => 2008-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 38938 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168250.pdf [firstpage_image] =>[orig_patent_app_number] => 12594951 [rel_patent_id] =>[rel_patent_doc_number] =>)